Abstract
This test is performed to assess suppressibility of cortisol in patients with an equivocal screening test such as overnight d1-mg examethasone (dex) suppression test, 24 h urinary free cortisol, and/or late night salivary cortisol.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
FormalPara Indication:To assess suppressibility of cortisol in patients with an equivocal screening test such as overnight 1 mg examethasone (dex) suppression test, 24 h urinary free cortisol, and/or late night salivary cortisol.
FormalPara Preparation:None.
FormalPara Materials Needed:Eight dexamethasone 0.5 mg tablets
One gold top tube for cortisol
Chemiluminescence Immunoassay (CLIA) .
FormalPara Precautions:None.
FormalPara Interpretation:Serum cortisol concentration > 1.4–1.8 µg/dl after 2 day low dose dex is strongly suggestive of Cushing’s syndrome [1].
FormalPara Caveats:-
Use of the 2 mg 2-day test has greater specificity at high sensitivity compared to the 1 mg overnight test. However, it requires more patience on the part of the patient [2, 3].
-
We do not recommend 24 h urine cortisol measurement during 2 mg dexamethasone suppression test (DST) because measurement of serum cortisol concentration during the low dose dexamethasone test is simpler and more reliable than measurements of urinary steroids [3].
-
Do not use this test if the patient is on estrogens which increase cortisol binding globulin (CBG) and falsely elevate cortisol levels [4].
-
Drugs such as phenytoin, phenobarbital, phenobarbitone, carbamazepine, rifampicin, and alcohol induce hepatic enzymatic clearance of dexamethasone, mediated through CYP 3A4, thereby reducing the plasma dexamethasone concentrations and may be associated with a false positive result [5].
-
To evaluate for false-positive and negative responses, some experts have advocated simultaneous measurement of both cortisol and dexamethasone during dexamethasone suppression tests to ensure adequate plasma dexamethasone concentrations.
Completed as outpatient
-
1.
Instruct patient to begin dexamethasone tablets. Patient takes one tablet every 6 h for a total of 8 doses (8 am, 2 pm, 8 pm, and 2 am). Some clinicians prefer a different schedule such as 6 am, 12 pm, 6 pm, and 12 am as a more convenient alternative. Studies were performed in the former schedule.
-
2.
6 h after the last dose, draw blood for cortisol (8 am).
-
Cortisol level at the end of the test: ______________________
-
Date and time of the cortisol: ___________________________
-
Physician name and signature: ▁
RN performing the procedure: ▁
Additional orders by physician: ▁
References
Isidori AM, Kaltsas GA, Mohammed S, et al. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab. 2003;88(11):5299–306.
Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing’s syndrome. Br Med J Clin Res Ed. 1984;289(6453):1188–91.
Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab. 2007;92(4):1326–33.
Kyriazopoulou V, Vagenakis AG. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. J Clin Endocrinol Metab. 1992;75(1):315–7.
Meikle AW. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol (Oxf). 1982;16(4):401–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ergin, A., Hamrahian, A., Kennedy, A., Gupta, M. (2015). Two Day Low Dose Dexamethasone Suppression Test. In: The Cleveland Clinic Manual of Dynamic Endocrine Testing. Springer, Cham. https://doi.org/10.1007/978-3-319-13048-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-13048-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13047-7
Online ISBN: 978-3-319-13048-4
eBook Packages: MedicineMedicine (R0)